Discover how cytoskeletal gene alterations create resistance to sorafenib in hepatocellular carcinoma and the implications for future cancer treatments.
Discover how the ETV6-miR-429-CRKL regulatory circuitry contributes to hepatocellular carcinoma aggressiveness and potential therapeutic approaches.